METS-IR, a Novel Simple Insulin Resistance Index, is Associated with NAFLD in Patients with Type 2 Diabetes Mellitus.
Xuan MaBaolan JiWenhua DuShuwei ShiHongyan ZhaoJie ShengXinghe JiangBo BanGuanqi GaoPublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2024)
In patients with T2DM, METS-IR is closely associated with NAFLD, and might be a valuable predictor of NAFLD. Further research is needed to verify this association.